# | Aladdin ID | Assay Type | Description | Organism | Compounds | Reference | BAO Format | Source | |
---|---|---|---|---|---|---|---|---|---|
1. | ALA656316 | F | Inhibition of MDC-stimulated chemotaxis in transfected murine cell line expressing human chemokine receptor 4 | 2 | ALA1148225 | cell-based format | Scientific Literature | ||
2. | ALA656317 | F | Dose required to inhibit TARC-stimulated chemotaxis in CCR4+ Th2 cell lines derived from primary human T-cells | 1 | ALA1148225 | cell-based format | Scientific Literature | ||
3. | ALA656318 | B | Inhibition of [125I]MDC binding to recombinant human C-C chemokine receptor type 4 (CCR4) expressed in murine pre-B cells | 86 | ALA1148225 | cell-based format | Scientific Literature | ||
4. | ALA656319 | B | Inhibitory effect on the binding of [125I]TARC to C-C chemokine receptor type 4-expressing CHO cells | 1 | ALA1133188 | cell-based format | Scientific Literature | ||
5. | ALA656490 | B | Inhibitory activity against C-C chemokine receptor type 4 | 7 | ALA1133866 | single protein format | Scientific Literature | ||
6. | ALA656491 | B | Compound was evaluated for its inhibitory activity against C-C chemokine receptor type 4 | 6 | ALA1133867 | single protein format | Scientific Literature | ||
7. | ALA656552 | B | The compound was tested for inhibition of Chemokine (SDF-1Alpha) binding CX3C chemokine receptor 4 transfected in HEK 293 cells | 1 | ALA1131251 | cell-based format | Scientific Literature | ||
8. | ALA662156 | B | Compound concentration that causes 50 % inhibition of binding of specific radioligand to human CCR4 receptor | 1 | ALA1133796 | single protein format | Scientific Literature | ||
9. | ALA662158 | B | Compound was tested for binding of the mAb (12G5) to the Chemokine receptor type 4 at 0.13 uM | 1 | ALA1132142 | single protein format | Scientific Literature | ||
10. | ALA662159 | B | Compound was tested for binding of the mAb (12G5) to the Chemokine receptor type 4 at 16 uM | 1 | ALA1132142 | single protein format | Scientific Literature | ||
11. | ALA662160 | B | Compound was tested for binding of the mAb (12G5) to the Chemokine receptor type 4 at 81 uM | 1 | ALA1132142 | single protein format | Scientific Literature | ||
12. | ALA660273 | B | Compound was tested for binding of the mAb (12G5) to the Chemokine receptor type 4 at at 0.65 uM | 1 | ALA1132142 | single protein format | Scientific Literature | ||
13. | ALA660274 | B | Compound was tested for binding of the mAb (12G5) to the Chemokine receptor type 4at 3.2 uM | 1 | ALA1132142 | single protein format | Scientific Literature | ||
14. | ALA660820 | B | Inhibitory activity against [125I]MDC binding to human Chemokine receptor type 4 expressed in murine pre-B cells | 1 | ALA1148225 | cell-based format | Scientific Literature | ||
15. | ALA660821 | B | Compound was tested for binding of the mAb (12G5) to the CXCR4 receptor at 18 uM | 1 | ALA1132142 | single protein format | Scientific Literature | ||
16. | ALA660822 | B | Compound was tested for binding of the mAb (12G5) to the CXCR4 receptor at 92 uM | 1 | ALA1132142 | single protein format | Scientific Literature | ||
17. | ALA660823 | B | Compound was tested for binding of the mAb (12G5) to the Chemokine receptor type 4 at 0.15 uM | 1 | ALA1132142 | single protein format | Scientific Literature | ||
18. | ALA660824 | B | Compound was tested for binding of the mAb (12G5) to the Chemokine receptor type 4 at 0.73 uM | 1 | ALA1132142 | single protein format | Scientific Literature | ||
19. | ALA660825 | B | Compound was tested for binding of the mAb (12G5) to the Chemokine receptor type 4 at 3.7 uM | 1 | ALA1132142 | single protein format | Scientific Literature | ||
20. | ALA660826 | B | Compound was tested for binding of the mAb (12G5) to the CChemokine receptor type 4 at at 0.73 uM | 1 | ALA1132142 | single protein format | Scientific Literature |